Friday was a devastating day for the pharmaceutical industry. In addition to Pfizer’s announcement about Celebrix, drug companies AstraZeneca and Eli Lilly also disclosed serious problems with drugs of their own. AstraZeneca revealed tests show that its lung cancer drug, Iressa, did not prolong lives. And Eli Lilly warned doctors that, Strattera, its drug to fight attention deficit disorder drug has caused severe liver injury in at least two patients. The announcements resulted in the three companies losing a total of $30 billion in stock value.